References
- Brasseur F., Couvreur P., Kante B., Deckers-Passau L., Roland M., Decker C., Speiser P. Actinomycin D absorbed on polymethyl cyanoacrylate nanoparticles: increased efficiency against an experimental tumor. European Journal of Cancer 1980; 16: 1441–1445
- Couvreur P., Kante B., Grislain L., Roland M., Speiser P. Toxicity of polyalkyl cyanoacrylate nanoparticles II. Doxirubicin-loaded nanoparticles. Journal of Pharmaceutical Sciences 1982; 71: 790–792
- Grislain L., Couvreur P., Lenaerts V., Roland M., Deprez-Decampeneere D., Speiser P. Pharmacokinetics and distribution of a biodegradable carrier. International Journal of Pharmaceutics 1983; 15: 335–345
- Kreuter J., Hartmann H. R. Comparative study on the cytostatic effects and the tissue distribution of 5-fluorouracil in a free form and bound to polybutyl cyanoacrylate nanoparticles in sarcoma 180-bearing rats. Oncology 1983; 40: 363–366
- Kreuter J., Tauber U., Illi V. Distribution and elimination of poly(methyl-2–14C-methacrylate)nanoparticles radioactivity after injection in rats and mice. Journal of Pharmaceutical Sciences 1979; 68: 1443–1447
- Kreuter J., Wilson C. G., Fry J. R., Paterson P., Ratcliffe J. H. Toxicity and association of polycyanoacrylate nanoparticles with hepatocytes. Journal of Microencapsulation 1984; 1: 253–257
- Lenaerts V., Nagelkerke J. F., Berkel T. J. C., Couvreur P., Grislain L., Roland M., Speiser P. In vitro uptake of polyisobutyl cyanoacrylate nanoparticles by rat liver Kupffer, endothelial and parenchymal cells. Journal of Pharmaceutical Sciences 1984; 73: 980–981
- Leonard F., Kulkarni R. K., Brandes G., Nelson J., Camerson J. Synthesis and degradation of poly(alkyl-cyanoacrylates). Journal of Applied Polymer Sciences 1966; 19: 259–272
- Senyei A. E., Reich S. D., Goncyz C., Widder K. J. In vivo kinetics of magnetically targeted low dose doxorubicin. Journal of Pharmaceutical Sciences 1981; 70: 389–391